PP2A Is Required for B Cell Survival and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia

被引：4
|
作者：
Gang, Xiao [1 ]
Geng, Huimin [2 ]
Chan, Lai N. [1 ]
Chen, Zhengshan [1 ]
Jiang, Xiaoyan [3 ]
Muschen, Markus [1 ]
机构：
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Lab Med, San Francisco, CA 94143 USA
[3] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
10.1182/blood.V126.23.3900.3900
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia
    Lu, Zhen
    Lai, Qian
    Li, Zhi-feng
    Zhong, Meng-ya
    Jiang, Yue-long
    Feng, Li-ying
    Zha, Jie
    Yao, Jing-wei
    Li, Yin
    Deng, Xian-ming
    Xu, Bing
    CURRENT MEDICAL SCIENCE, 2024, 44 (02) : 298 - 308
  • [42] Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia
    Savino, Angela Maria
    Izraeli, Shai
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (03) : 183 - 185
  • [43] STAT5-A new therapeutic target in acute lymphoblastic leukemia?
    Jorge, Joana
    Estevam, Alexandre
    Alves, Raquel
    Lapa, Beatriz
    Nascimento-Costa, Jose Manuel
    Goncalves, Ana Cristina
    Sarmento-Ribeiro, Ana Bela
    MEDICINE, 2020, 99 (23)
  • [44] Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
    Mendoza, Miguel Enrique Cuellar
    Sanchez, Francisco Raul Chavez
    Acosta, Elisa Maria Dorantes
    Zuniga, Ana Maria Niembro
    Pelayo, Rosana
    Tarres, Marta Zapata
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Aurora B kinase as a therapeutic target in acute lymphoblastic leukemia (vol 85, pg 773, 2020)
    Goto, Hiroaki
    Yoshino, Yuki
    Ito, Mieko
    Nagai, Junichi
    Kumamoto, Tadashi
    Inukai, Takesi
    Sakurai, Yukari
    Miyagawa, Naoyuki
    Keino, Dai
    Yokosuka, Tomoko
    Iwasaki, Fuminori
    Hamanoue, Satoshi
    Shiomi, Masae
    Goto, Shoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (06) : 1055 - 1056
  • [46] Btk and NFκB as prognostic biomarkers and potential therapeutic targets in B cell acute lymphoblastic leukemia
    Tao, Shandong
    Wang, Chunling
    Chen, Yue
    Deng, Yuan
    Zhou, Litao
    Zhang, Xin
    He, Zhengmei
    Yu, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 7995 - 8005
  • [47] THE PRE-B-CELL RECEPTOR PATHWAY IS A THERAPEUTIC TARGET IN SPECIFICALLY TCF3-REARRANGED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Van Der Veer, A.
    Van Der Velden, V.
    Willemse, M.
    Hoogeveen, P.
    Petricoin, E.
    Beverloo, H.
    Escherich, G.
    Horstmann, M.
    Pieters, R.
    Den Boer, M.
    HAEMATOLOGICA, 2013, 98 : 2 - 2
  • [48] Tissue transglutaminase is a new therapeutic target to overcome steroid resistance in T cell acute lymphoblastic leukemia
    Jung, Hyun Joo
    CANCER RESEARCH, 2017, 77
  • [49] Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia
    Kaushik, Bhupendra
    Pal, Dilipkumar
    CURRENT DRUG TARGETS, 2021, 22 (15) : 1789 - 1798
  • [50] Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
    Boullosa, Laurie Freire
    Savaliya, Payalben
    Bonney, Stephanie
    Orchard, Laurence
    Wickenden, Hannah
    Lee, Cindy
    Smits, Evelien
    Banham, Alison H.
    Mills, Ken I.
    Orchard, Kim
    Guinn, Barbara-Ann
    ONCOTARGET, 2018, 9 (03) : 3853 - 3866
12345